Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund

6. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders In Q3 2024: 106

Eli Lilly and Company (NYSE:LLY) is a pharmaceutical company that’s a common feature of Cramer’s morning shows. He favors the firm’s weight loss drugs over rival Novo Nordisk’s due to higher prescription rates. More recently, the CNBC show host has switched to Eli Lilly and Company (NYSE:LLY)’s drug pipeline as a key driver of its hypothesis. He believes that investors need to look beyond the firm’s recent quarterly earnings and focus on the bigger picture. Cramer’s latest remarks added to this narrative:

“I mean Eli Lilly is in phase three for pill form. They have to take the pill every day. They’ve got so many different trials going on that they used the font that I couldn’t see it.”

“Right but you know what they’re doing? They’re putting up factories for things that have not been approved because they’re so confident they will be. I like that. I think that David Ricks is terrific. Absolutely terrific.”

“And I like the fact that David Ricks has said I want a moat. And the moat is going to be that these are really hard factories, it’s gonna be like foundries.”

“They’ve got trials going on where it just seems like you’d be nuts not to take the drug if you have a comorbidity. And they need to get approval for a lot of health insurers. But it’s an excellent situation. Ricks is good. He kind of screwed up, he was on my show, our show, and at the end of it, it was like, hey David, what was that? Do over? Now there’s no do overs! It was live tv!”